| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |